News Chemistry Industry / DeepDyve
· Regulations Indian drug approvals come under ï¬ re Mandakini Gahlot A report tabled in the Indian parliament in May 2022 has accused the countryâ s drug regulator of being the agents of multinational pharmaceutical companies and claims that many drugs are receiving market clearance without sufï¬ cient trial data On average the report authors say that one drug/month is being